Elevance Health (NYSE:ELV) Stock Rating Upgraded by StockNews.com
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Saturday. A number of other research firms also recently weighed in on ELV. Barclays increased their price target on shares of Elevance Health from $501.00 to $512.00 […]
